Category: seroxat

Fiddaman Blog: Dolin Vs GSK


Well done to Wendy, her legal team, and Bob Fiddaman! (and Leonie, Kim, Steph and the others) Great to see justice being served!


Thursday, April 20, 2017

Dolin Vs GSK – The Verdict

http://www.facebook.com/plugins/like.php?href=http://fiddaman.blogspot.ie/2017/04/dolin-vs-gsk-verdict.html&layout=button_count&show_faces=false&width=100&%20action=like&font=arial&colorscheme=light

GlaxoSmithKline have been found guilty by a jury today in Chicago.

The jury found for plaintiff, Wendy Dolin, who filed suit against GlaxoSmithKline after her husband, Stewart, took his life 6 days after being started on a generic version of Glaxo’s controversial antidepressant Paxil (known as Seroxat in Europe)

A huge congratulations to Wendy and her legal team; Brent Wisner of Baum, Hedlund, Aristei & Goldman, PC, Los Angeles and David Rapoport of Rapoport Law Offices, Chicago.

Updates coming later. In the meantime, here’s some of the reasons why the jury returned a guilty verdict. Click on images to enlarge. Images courtesy of Baum Hedlund.


Bob Fiddaman

Back stories

Dolin Vs GSK

Dolin v GSK – Opening Arguments

Dolin Vs GSK – Day Two – “Jack-In-The-Box”

Dolin vs GSK – Healy ‘Rocks Da House’

Dolin Vs GSK – JP Garnier Video Deposition

Dolin Vs GSK – The Dunbar Tape

Dolin Vs GSK – Day 4 – Slam Dunk

Dolin Vs GSK – 8.9 Suicide Increase For Adult Paxil Users

Dolin Vs GSK – Day 6 – Ass Kicking Semantics

Dolin Vs GSK – Day 7 – Abraham Lincoln

Dolin Vs GSK – Day 8 – Get to the Point, Todd!

Dolin Vs GSK – Glenmullen Nails It!

Dolin Vs GSK – “Babes”

Dolin Vs GSK – Wendy’s Cross and GSK’s Petition

Dolin Vs GSK – Robert “Bling Bling” Gibbons

Dolin Vs GSK: Suicide Prevention Warning “Futile”, Claims GSK Exec

Dolin Vs GSK : Jury shown List of the Dead in Paxil Clinical Trials

Dolin Vs GSK: Last Man Standing & The Return of Dr. Healy

Dolin Vs GSK: Closing Arguments

Victory For Wendy Dolin! GSK must pay $3 mln in generic Paxil suicide lawsuit..


http://www.nasdaq.com/article/gsk-must-pay-3-mln-in-generic-paxil-suicide-lawsuit-us-jury-20170420-01702

GSK must pay $3 mln in generic Paxil suicide lawsuit: U.S. jury

 

sonreuters.com; Twitter @nateraymond;

+1-617-856-1312; Reuters Messaging:
nate.raymond.thomsonreuters.com@reuters.net))

GSK must pay US$3 million in generic Paxil suicide lawsuit: US jury

REUTERS: GlaxoSmithKline must pay US$3 million to a woman who sued the drug company over the death of her husband, a lawyer who committed suicide after taking a generic version of the antidepressant Paxil, a U.S. jury said on Thursday.

The jury’s award followed a trial in federal court in Chicago in a lawsuit over the death of Stewart Dolin, a partner at Reed Smith LLP who jumped in front of an oncoming commuter train in 2010 after taking a generic equivalent of GSK’s Paxil.

The verdict by the nine-member jury in favor of Dolin’s wife, Wendy Dolin, was confirmed by GSK, which said in a statement it was disappointed and planned to appeal.

“GSK maintains that because it did not manufacture or market the medicine ingested by Mr. Dolin, it should not be liable,” GSK said. “Additionally, the Paxil label provided complete and adequate warnings during the time period relevant to this lawsuit.”

Brent Wisner, a lawyer for Wendy Dolin, said his client was “very pleased” with the verdict, adding that “justice has been served.”

Wendy Dolin filed the lawsuit in 2012 against London-based GSK and Mylan, which manufactured paroxetine hydrochloride, the generic version of Paxil her 57-year-old husband was taking before his suicide.

A federal judge dismissed Mylan from the lawsuit in 2014 but allowed Dolin to proceed against GSK because it controlled the drug’s design and label, which applied to both the brand-name and generic versions of the drug.

The label included a “black box” warning that paroxetine, like all SSRI-type antidepressants, can increase the risk of suicidal behavior by users under age 25.

At trial, Dolin’s lawyers had requested US$39 million. They alleged GSK had evidence paroxetine increases the risk of suicide by older users by as much as 670 percent, yet failed to include that on the warning label.

In his opening statement on March 14, GSK attorney Andrew Bayman said the label was appropriate and its wording was mandated by the U.S. Food and Drug Administration.

The case is Dolin v. GlaxoSmithKline, U.S. District Court, Northern District of Illinois, No. 12-cv-6403.

(Reporting by Nate Raymond in Boston and Barbara Grzincic in Baltimore; Editing by Cynthia Osterman)

Andrew Bayman, King & Spalding (GSK’s defence team)’s absurd and ridiculous closing statement..


“Don’t you think if these medicines caused suicide someone would have spoken up?” ~

Andrew Bayman, King & Spalding (GSK’s defence team) during closing arguments to the jury yesterday…. ”

http://fiddaman.blogspot.ie/

Andrew Bayman (lawyer for King And Spalding’s -Paxil defense for GSK- in the Stewart Dolin ‘Paxil/Seroxat Induced Suicide trial’) uttered possibly the most absurd and ridiculous thing I have ever heard in relation to Paxil (and believe me- after ten years blogging I’ve heard it all).

He said:

“Don’t you think if these medicines caused suicide someone would have spoken up?”

I find this statement hilarious. There has been 4 BBC Panorama documentaries about Seroxat (Paxil) and numerous blogs, documentaries, etc over almost two decades now- all documenting the dangers of Paxil and SSRI’s. There are dozens of SSRI support groups online, and much media attention of their dangers over the years. I’ve been blogging for ten years about the dangers of Paxil and other SSRI drugs (there’s over 1000 blog posts on here).

Bob Fiddaman has been blogging just as long about the same issues. Seroxat Secrets blogged for the guts of several years also about the dangers of Paxil/Seroxat (and his recent post shows that he is still speaking out!).

People have been speaking out for almost two decades. Thousands of people, tens of thousands of people actually….


See Seroxat Secrets- Below- and  here

Yes, I know it has been a while…

I’m just in the process of looking back at my time on Seroxat and my withdrawal from it. I can’t say what for at the moment, but watch this space….

Looking back at my blog I can remember how important it seemed at the time to use the internet to get the message out there that there were problems with Seroxat. Of course, over the past 11 years we have come to understand that there are problems with many SSRIs and other drugs. There are also problems with the way big Pharma goes about its business – from rigging drug trials to marketing unsafe drugs to the public.

I’m lucky, I have been able to move on in my life and I leave this blog on the internet to help anyone who is suffering the same way I did in the hope it may be able to help in some small way.

Back in 2005/2006 there was a only handful of us who were using the internet to warn of the problem of Seroxat. Happily now there are far more people and organisations that write about this subject and I hope it’s more widely known by the general pubic and medical professionals alike.

If you haven’t visited these sites, you should:

Leonie Fennell

Dr David Healy

AntiDepAware

GSK: Licence to (K)ill

The Pill that Steals

There’s a trial going on the US at the moment – the crux of the matter in Dolin Vs GSK is whether or not Paxil (Seroxat) caused Stewart Dolin to kill himself whilst under Paxil’s influence – and just what GSK did to hide the truth about the dangers of their drug.

The trial is being covered the mainstream media and by Bob Fiddaman on his blog, and below here are some links to the story so far.

Dolin v GSK – Opening Arguments

Dolin Vs GSK – Day Two – “Jack-In-The-Box”

Dolin vs GSK – Healy ‘Rocks Da House’

Dolin Vs GSK – JP Garnier Video Deposition

Dolin Vs GSK – The Dunbar Tape

Dolin Vs GSK – Day 4 – Slam Dunk

Dolin Vs GSK – 8.9 Suicide Increase For Adult Paxil Users

Dolin Vs GSK – Day 6 – Ass Kicking Semantics

I think that both Bob and I enjoy watching GSK squirm, but what’s important from a wider perspective is the way that a trial brings previously secret information into the public domain. Each trial that takes place opens the curtains a little wider.

I hope that the trial will bring closure for Stewart Dolin’s widow, Wendy. What GSK and their lawyers always forgets is that are real people and real tragedies at the sharp end of the unsafe drugs they choose to bring to market and make huge profits from.

There’s also an action nearing trial in the UK at the moment, and as I wrote previously: The publicity of a High Court hearing will mean the mainstream press  will be free to report on ALL the evidence presented. Now… I’m thinking that this will mean a lot of GSK documents that have until now remained secret will become very public knowledge. You see a case like this, while common in the USA, is unheard of in the UK and the publicity it will generate will be huge. And all those once-secret documents and the information they hold will be available the world over for future claimants to use. I think a whole new raft of claims will be kick-started in the USA alone. I wonder what GSK’s share price will look like after all this? And how institutional investors will view a company that breaks the law and lies & cheats its way to profit?

In the 21st century, ethos & culture – the way a company actually operates and conducts its business – are as important to a PLC as having a blockbuster product to sell. Ethos & culture are intrinsic parts of a modern corporate brand, going way beyond the generic, meaningless mission statement that we see from GSK “…to help people do more, feel better, live longer”.

I’d like to finish on a personal note. Perhaps, after all these years, I’m getting nearer to closure. For me, that simply means people will believe what happened to me was real.

More importantly, I hope that Doctors will understand what happened to me was real – and perhaps then we can start to help others who are going through the horrors of withdrawing from Seroxat/Paxil today.


 

There was even a protest some 12 years ago. A Paxil survivor, and activist, Rob Robinson, was so enraged about Paxil that he flew a plane around GSK’s Philly HQ!…

See the pics below from the Paxil Protest (see the archive here)

 

 

Consumers Join Forces to Protest Against Antidepressant Paxil and Kickoff Boycott of Drug Company GlaxoSmithKline (press release)

Monday, September 12, 2005
by Mike Adams, the Health Ranger
Editor of NaturalNews.com (See all articles…)
Tags: pharmaceutical fraud, health news, Natural News
Delicious
0
diaspora

Consumer drug advocates from across the United States, Canada and elsewhere are converging on drug giant GlaxoSmithKline’s US corporate headquarters located in Philadelphia, PA this September 26th through 28th in what could turn out to be a massive demonstration against the company’s top selling drug called Paxil. The event is called the “Paxil Protest.”

“Paxil is a dangerous and defective drug. That is absolutely the case,” said Rob Robinson, the event’s organizer. “The swath of devastation, misery and sometimes death which Paxil has unleashed the world over is simply staggering. Yet GlaxoSmithKline has done everything in its power to keep the sinister truth about Paxil from going public. What’s at stake for the company is a multibillion dollar revenue stream that sales of Paxil have generated for almost ten years.”

“GlaxoSmithKline has claimed since 1992,” Robinson said, “that Paxil is ‘safe and effective’ after it was approved by the Food and Drug Administration — end of story. But it’s the beginning of the story which GSK conveniently forgets, or rather doesn’t want the world to know about, and that is the fact that Paxil’s FDA approval was based on the company’s submission of fraudulent Phase III clinical trials. As such, GSK’s claim that Paxil is ‘safe and effective’ is specious at best.”

“The truth is Paxil represents the greatest fraud ever perpetuated within the pharmaceuticals industry,” Robinson said. “But thanks to the unsparing efforts of attorneys representing Paxil victims evidence of this fraud has been uncovered in GlaxoSmithKline’s confidential files. One trial and it all comes out. And that is going to be one huge news story — on the order of Merck’s Vioxx.”

A much anticipated Paxil trial set to take place May 2nd of this year was delayed for at least another six months. Robinson says he is not surprised: “GSK has spent hundreds of millions of dollars fighting to keep the truth about Paxil from coming out, but at the end of day I’m confident the company’s efforts will fail.”

Approximately 5,000 U.S. citizens have filed suit against GlaxoSmithKline asserting they became addicted to Paxil and then suffered withdrawals when quitting the drug as a consequence of the company failing to warn them of the drug’s dangers. Several thousand more persons have sued GlaxoSmithKline in the UK on the same basis. “Paxil’s reach extends into medicine cabinets the world over, and cuts across all social classes,” Robinson said. “Paxil is an equal opportunity destroyer.”

Some lawsuits filed against GlaxoSmithKline are on behalf of patients who started Paxil — only to discover they could not stop taking the drug, even with expert medical help. (One patient in Britain was told by her doctors that ‘heroin would have been easier to wean [herself] off and recover from.’)

“Paxil withdrawal symptoms can be so severe and protracted it requires an almost superhuman strength to endure them,” Robinson said. “Not surprisingly, some people cannot, and as a consequence commit suicide. Others victims have resumed use of Paxil to escape withdrawal symptoms, but will have to take the drug for the rest of their lives whether they want to or not. In other words, they’ve become lifetime Paxil addicts.”

Robinson stated that a review of the medical literature shows that, on average, over one-third of people taking Paxil for any extended period of time experience withdrawal symptoms, and of those, 21% experience severe withdrawal symptoms. In the clinical trials of Paxil, a significant percentage of patients (up to 50% according to some studies) experienced withdrawal.

“There is a huge disconnect between what GSK tells the public about Paxil, and what the truth about Paxil is. That disconnect extends to GlaxoSmithKline’s labeling of the drug throughout the world. GSK is a very big company with an even bigger problem of telling the truth,” Robinson said.

In an October 19, 2000 deposition taken of Dr. David Wheadon, Senior Vice President of Regulatory Affairs and Product Professional Services for GlaxoSmithKline, Dr. Wheadon stated “there have been a number of systematic studies in humans looking at the potential for Paxil for abuse, tolerance and physical dependence. So actually, there is data to date to negate the statement that it has not been systematically studied, because, in fact, it has been.” However, Paxil’s June, 2005 drug labeling states “Paxil has not been systematically studied in animals or humans for its potential for abuse, tolerance or physical dependence.”

At the time of Dr. Wheadon’s testimony Paxil’s U.S. drug label claimed: “Paxil is non-habit forming, may cause mild, usually temporary, side effects in some individuals” and further that Paxil “has been studied both in short-term and long-term use and is not associated with dependence or addiction.” “Those claims are now known to be utterly false,” said Robinson.

“No discerning member of the public, or the press, will believe that Dr. Wheadon was simply mistaken or ill-informed at the time of his year 2000 deposition,” Robinson said. He (Wheadon) knows as much about Paxil as anybody at Glaxo; all one has to do is peruse his sworn testimony to see that’s clearly the case.” (Access Dr. Wheadon’s complete testimony at the Paxil Protest web site.)

Dr. Wheadon’s association with Paxil spans two decades; he was part of the original GSK team which presented Paxil’s clinical trials during the FDA’s October 5th, 1992 hearing wherein the company first sought — and later gained — the agency’s approval for the drug.

A Paxil Protest web site, launched on August 8th, 2005, has already received over a quarter of a million ‘hits.’ “The response from the public has been one of exuberance. Which is hardly surprising given the fact that this represents the first time in history a multinational drug company has successfully been targeted using the Internet as a public relations weapon,” Robinson said. “The Internet is providing the public the matchless ability to organize and direct participants ‘on the ground’ and to further respond in real time to a highly fluid and dynamic public relations environment. It’s almost like having the equivalent of an AWACS radar plane circling over a public relations battlefield.”

The Paxil Protest web site, well organized and easy to navigate, lays out a compelling indictment not only of Paxil, but also of GlaxoSmithKline. “Virtually all of what you’ll see at the Paxil Protest web site was assembled from news stories, medical journals, depositions and the like. It was simply a matter of pulling all the facts together into one big package for the public,” Robinson said. “I challenge GlaxoSmithKline to dispute the accuracy and veracity of anything published to the web site.”

The Paxil Protest web site also includes important information for Paxil users who might wish to quit the drug. “What I did not want to have happen is to have Paxil users come to the site, panic, and then abruptly quit the drug. The consequences could be disastrous. That’s why an entire web page addresses the issue of how to get off Paxil safely, or as safely as possible.”

“I am confident the public as well as the media will discover information that is newsworthy and highly informative on virtually every page of the Paxil Protest web site” Robinson said. “Plenty of story angles to be had,” he added.

Robinson, a Paxil survivor himself, said it took several years of intermittent but intensive research to assemble the information presented at the Paxil Protest web site. “My goal was to make it as easy as possible for the public to get to the truth about Paxil — the sinister truth which GlaxosmithKline hides from the world.” He describes the Paxil Protest web site as ‘the definitive Paxil Information Clearinghouse.’

As many as 1,000 or more protesters might attend the Paxil Protest. “We simply have no way of forecasting how many people might show up; after all, the call to action is going out the world over,” Robinson said.

Victims and survivors of other SSRI drugs such as Prozac, Effexor and Zoloft are also expected to attend in a show of community support.


Glaxo’s Last Mudslinging Act At The Stewart Dolin Paxil Trial..


Page_1

GGG.png

“….Next came the issue of Rothschild’s cozy relationship with GlaxoSmithKline. In the Dolin case alone, Rothschild has been paid approximately $165,000 for his testimony.

Rapoport pressed Rothschild further and asked him about previous cases where GSK has called him as an “expert” witness.

When asked how many times GSK has hired him as a witness in Paxil death cases, Rothschild couldn’t seem to count that high. “Going back 15 years, I can’t give you an exact number, but it’s probably in the neighborhood of 20 or 30.”…”

-Bob Fiddaman:

http://fiddaman.blogspot.ie/


Two weeks ago, I decided to take a blog-break due to some health issues which I need to try to attend to. I still intend to pull back from blogging, as blogging about this stuff can be exhausting at times, however I feel It’s important to highlight the Stewart Dolin Paxil induced suicide trial currently ongoing in the US.

It seems to me that Glaxo’s case in defending Paxil, has been more of a masterclass in mudslinging as opposed to a legitimate defense of their drug. They seem to think that if they hire every pharma-whore they can find available and get those pharma-whores to sling mud at Stewart Dolin’s character, then that will be enough to sway the jury that it was not Paxil which caused Stewart to kill himself.

Pretty pathetic on Glaxo’s part, in my opinion.

Bob Fiddaman has been covering the Dolin trial on his blog for a few weeks, and his last two posts show just how desperate Glaxo are to deny that Paxil (seroxat) can cause suicide and akathisia.

It is simply astounding how GSK can try to defend Paxil/Seroxat in court on the premise that Paxil doesn’t cause suicide or akathisa, while at the same time, they admit in their PIL’s (Patient information leaflets) that Paxil can induce suicidal thoughts/ideation, akathsia and changes in behavior etc.

You can’t have it both ways, but it seems that isn’t going to stop Glaxo from trying.

One of Glaxo’s so called ‘experts’ in the Dolin trial is Dr Anthony Rothschild. Rothschild has apparently been defending GSK’s Paxil/Seroxat in possible Paxil induced suicide cases for many years.

I wonder how much money Dr Rothschild has made over the last 15 years defending Paxil? If he got over 150,00 dollars for one appearance, and he has done 20 to 30, for Glaxo, then perhaps defending Paxil alone has made him a millionaire?

You’d have to wonder too, does Dr Rothchild care about the wellbeing of those prescribed SSRI’s like Paxil?, does he care about the truth of the side effects of these drugs seeing the light of day? or does he care more about the hundreds of thousands of dollars he receives per court appearance from GlaxoSmithKline? and the monetary grants and honoria he receives from the drug industry?

I think astute readers will come to their own conclusions about that.

Seroxat/Paxil does cause Akathisia, I experienced it myself, and so have many others. Paxil/Seroxat does cause suicidal behaviors, I experienced this too, and so have many others. GSK are proven liars, fraudsters, felons and criminals. Anyone who takes blood money from them- to defend their drugs in cases where their drugs have caused harm- does not have the public’s best interest at heart.

Furthermore, greedy doctors on a drug company’s pay-roll certainly don’t have their patients’ interests at heart.

Dr Rothschild (and those of his ilk) make an absolute mockery of the medical Hippocratic oath..

“First do no harm”..

See Fid’s post here for more

 

Final Post For The Foreseeable Future..


  • Emma Walmsley is set to become boss of drugs giant GlaxoSmithKline

  • She will be the first female chief executive of the £80 billion company

  • 47-year-old used to work for French beauty giant L’Oreal 

  • Lives with her family in a £3.7 million house in South-West London 


This will be my final post this year.

I’ve been blogging over 10 years, and It’s time I took a break. Blogging about a corrupt sociopathic drug company like GSK takes its toll. I’m tired.

GSK have a new CEO now, and I’m sure that the new CEO, Emma Walmsley, will continue in the vein of JP Garnier, and Andrew Witty. She will, no doubt, put profits before people, and her own self interest before the greater good. Emma will, most likely, like Andrew before her, earn tens of millions (possible even more) by the end of her stint as Glaxo CEO.

Let’s be honest, these jobs are primarily profit driven.

Emma Walmsley, or Andrew Witty, take the pressure and the heat of the CEO position because they are rewarded handsomely. They are hardly doing it for the sake of it.

The cash incentive is so high for these jobs because these pharmaceutical company positions require the CEO to literally delete their conscience (that’s if they have one in the first place).

The vast sums of money (the tens of millions GSK bestow upon the CEO) is the prize for selling their soul to the company, turning a blind eye to corrupt practices (such as the bribery scandal in China), believing the corporate bullshit they are spun, and the spin they croak themselves. They repeat the corporate mantras (such as: do more feel better, live longer) like some kind of brainwashed- incantation of a cult.

For the many tens of thousands of people prescribed Seroxat/Paxil who weren’t adequately warned of side effects, for the many people crippled from GSK’s Myodil dye, or for those prescribed many GSK drugs unethically off label (as detailed in Greg Thorpe’s Department of Justice complaint)- GSK’s mantra ‘do more, feel better, live longer is a surreal insult. It’s a disturbing catch phrase for those damaged by GSK products. Many of us cannot do more or feel better, because these GSK poisons have destroyed our lives, or stolen years from us- or our loved ones.

Andrew Witty is now gone, and Walmsley is in his place. Will she atone for GSK’s decades of corporate misconduct and harm to consumers and patients?

I doubt it..

Does she really give a damn?

Probably not..

Perhaps people like Witty and Walmsley believe that because GSK makes some meds that are helpful, and some products that are useful (such as toothpaste and painkillers), this balances out the dodgy drugs (such as Seroxat and Avandia) that cause harm? Perhaps this is how they square this off, morally, in their minds?

Personally, I cannot understand how they sleep at night, or how they can work for such a morally and ethically defunct company like GSK, but that’s for them to figure out, not me.

The Seroxat suicide controversy, particularly its horrific (often fatal) affect on teens and kids, and how GSK covered that- up would be enough for me to hand in my resignation, and run for the hills.

Would Emma Walmsley, or Andrew Witty, recommend Seroxat for their own kids? or their spouses? Would they take the risk?

I seriously doubt it.

Check out Emma Walmsley’s master class (in the vid below) in downplaying GSK’s many years of harm to patients over the years…

She’ll make a great CEO for GSK, they trained her well.

She’s a good candidate… she repeats the GSK corporate spin (almost) without even flinching…

She’ll be a good little robot..

She’ll do anything for the GSK blood money…

She’ll make a fortune..

Well done Emma..

Give yourself a pat on the back, and then go and salivate when you see your bank balance..

“Fitter Happier”: Radiohead


Some things to keep an eye on while I take my hiatus are :
The Stewart Dolin ‘Paxil Induced Suicide Trial’ (currently being covered by Bob Fiddaman, on his blog here)

I have no doubt that Paxil caused Stewart Dolin to commit suicide. His case is a classic case of ‘Paxil induced akathisia’. Akathisia is a hellish side effect from Paxil/Seroxat (all SSRI’s cause it). I had it many times on Seroxat and it literally pushes you over the edge. Suicide can be a welcome relief from the sheer torture of it. It is agonizing.

GSK did not warn properly of this side effect (and many other side effects) of Paxil, they should be held accountable- and I wish Stewart’s wife, Wendy, the best with this extremely important case.


Another Glaxo scandal emerging involves Tafenoquine (GSK’s ‘experimental’ anti-Malaria drug). Tafenoquine is of the same class of drugs as the controversial Lariam drug (which has been described as a ‘horror movie in a pill’ by some). It looks a bit dodgy to me, but no doubt GSK will be up to their usual shenanigans and they’ll push it on to the market anyway..

Check out some posts on Tafenoquine here:


Peter Humphrey is currently suing Glaxo for their devious behavior in China. That particular scandal cost GSK the guts of half a billion. I wish Peter the best with his lawsuit against them. There is no doubt in my mind that Glaxo scapegoated Peter and his wife, Yu. They have been treated appallingly by Glaxo. Keep an eye on Peter’s case in the media.

See here for more on Peter’s case


Another case to keep an eye out for involves GSK’s horrific Myodil dye.  Myodil has been maiming individuals, and destroying people’s lives, for decades. A landmark case (involving Myodil sufferer, and solicitor, Keith Lewin) just might blow the whole thing wide open again. Hopefully we will hear good news coverage of this case and the many victims of this horrible GSK product can have their voices heard. I wish Keith all the best with his important case.

See here for more:


I’ll leave the last comment to GSK whistle-blower, Greg Thorpe. Greg blew the whistle on GSK’s corrupt practices and this led to GSK’s 3 Billion fine for fraud in 2012 in the US.

https://truthman30.wordpress.com/2016/05/19/how-did-gsk-market-the-horrible-death-drug-seroxat-to-unsuspecting-doctors/

“…I have seen and witnessed first hand, worse marketing in the US…although the DOJ did not seem to interested in digging very deep with Paxil fraud.
Why, because they were protecting the executives, including the infamous JP Garnier, Bob Ingram, and others. This would include the criminal Witty, who had to know about Paxil. He was in the antidepressant marketing arm after the merger, the then “commoner”-Andrew Witty.

His transgressions and crimes were ignored by prosecutors…I believe so it would not interfere with his ungodly ” knighting”…He was there in the period after the merger, a main player in the Wellbutrin scams. Paxil and Wellbutrin were marketed in a way, so that business from one did not cannibalize the other one.

This was also another elaborate scheme, that I brought forward…in addition to my main concern, not only marketing both to children under 18….but for very young children also.

What can be said about a company that does this, with the knowledge hidden from physicians and patients ..resulting in unnecessary suicides-side effects (including horrible withdrawal symptoms),
and conning the gov’t and insurance companies into paying.

Now we see a couple minor players in the industry indicted and facing trial, for much less than the deadly “three amigos”, listed above. Smoke and mirrors, diversion from the worst of the worst.
So now all 3 living the good life on blood money, murder money or at the very least manslaughter.

It sickens me that I spent 12 years plus, shining some light on these cockroaches for nothing, not even a fine or any punishment worth a damn, end of story.

SIR Witty, can spin it all he wants. He along with all the others are truly pathological liars. If what I say is not true, the bastards have hundreds of GSK and other outside attorneys to sue me. I believe they spend more on attorneys to save themselves, rather than do any significant Research and Development…Judicial Watch, here in the US …has been informed of some of this, but has declined to investigate anything?

Who paid them off ?

The inside information is in the bowels of the DOJ, if they have not destroyed evidence already. Why they did not go all the way back to the year 1996, when they could have on Paxil and Wellbutrin is no mystery to me..Filing in Jan 2003, they had every right to, but again the whole illegally sealed case stinks and I am holding my nose trying to put my life back together…

It was all a sick joke, and they all are above the law, “to big to prosecute”. Now as I predicted with the non-penalty here, they have gone global, with Witty at the helm.
Everything else gets older every day, but there is no Statute of Limitations on criminal acts…and Witty, Garnier, Ingram, Viebacher, Stout, Rajaratnum and their foot soldiers, who orchestrated all these scams resulting in morbidity and mortality
should still be investigated….and not by a Crook like Eric Holder, once a GSK defender always a GSK defender and highly paid…both in govt. and by his cronies at the revolving door law firm…Covington Burling, a den of sociopaths in its own right. Justice it seems will never happen, at least on earth.

Keep plugging Truthman, I admire your tenacity…seemingly everyone else has clocked out and left. GSK is still there however, and as bad as ever…”

-G. Thorpe.

 

The Dolin Trial… Glenmullen Enters The Fray..


Thursday, March 30, 2017

Dolin Vs GSK – Glenmullen Nails It!

On Tuesday a series of video depositions were aired to the jury. Sadly, I have no access to the videos and cannot directly report on them. Thankfully, GSK’s lawyer, Todd Davis, has provided fabulous entertainment akin to a desperately sad clown. Yesterday Davis ineffectively cross-examined the plaintiff’s next expert witness, Dr. Joseph Glenmullen.

Dr. Glenmullen is yet another thorn in the side of GSK. He has previously served as expert witness in many Paxil lawsuits, and, just like Dr. David Healy, is disliked by GSK and their King &  Spalding attorneys. Both Glenmullen and Healy were subjected to GSK’s pre-trial circus in which GSK filed motion after motion arguing that these renowned doctors should not give evidence at this trial. GSK’s attempts were denied.

After yesterday, I can vividly see why GSK opposed Glenmullen as an expert. In short, Glenmullen ran circles around Davis. More on this further on down this blog post.

Glenmullen detailed Stewart Dolin’s medical notes and told the jury the akathisia Stewart experienced occurred the last time he was prescribed Paxil. This was six days before Stewart’s Paxil-induced death. During these six days, Stewart showed increased signs of agitation, just as he did when he was previously prescribed Zoloft years ago. In fact, when the Zoloft dose was increased, Stewart’s adverse drug reaction (akathisia) worsened. When Stewart stopped taking Zoloft, his agitation subsided. Sadly for Stewart and his survivors, when he last took Paxil his adverse drug reaction ended in death. Akathisia, as Glenmullen stated yesterday, is “a drug-induced reaction, a compulsion to kill yourself.” Glenmullen added that a death such as this is referred to “as a paroxetine-induced accident, not a suicide. It’s paroxetine. It’s the label that didn’t warn that is the cause.”

Regarding GSK’s supposed adult suicide warning on the Paxil labeling, Glenmullen clearly nailed it. Referring to the 2010 Black Box warning displayed in court, Glenmullen told the jury how there was explicit language that short-term studies did not show an increase in the risk of suicidality with antidepressants compared to sugar pills in adults beyond age 24. He also pointed out the sentence, “Depression and certain other psychiatric disorders are themselves associated with increases in risk of suicide.” He explained to the jury, “…What that tells me as a practicing psychiatrist is that if I’m treating a 57-year old patient and I put them on Paxil, Paxil couldn’t make them worse. Paxil couldn’t make them suicidal. It would be, and it says explicitly, their depression or other psychiatric condition.”

Glenmullen further noted the black box warning is “really bad” because it implies the suicide warning is just for children, ergo a doctor treating an adult could not warn about a potential risk of suicide because the labeling suggests there is only a suicidality risk among children taking Paxil.

The jury was informed that the labeling was written in such a way so that doctors would not only NOT know about the adult suicide risk, doctors would actually increase the dose because they would assume worsening of depression and/or new disturbing behaviors had nothing to do with Paxil.

Glenmullen added, “And here’s another dimension to it. If the patient gets worse and it might be the drug, what do you do? You take them off the drug to see. If they get worse and it couldn’t be the drug but it’s the depression, what do you do? You increase the drug, which is going to worsen the risk. So it’s very dangerous. And that’s why, in my opinion, it’s really this lack of a warning that’s responsible for his (Stewart Dolin’s) death.”

Glenmullen told the jury he is “100% certain” that “Mr. Dolin’s was a “paroxetine-induced, Paxil-label-induced death.”


Cross-examination by King & Spalding’s Resident Clown

As per his norm, Davis repeatedly tried but failed to discredit the witness. He attempted to catch out Glenmullen with answers Glenmullen provided in various testimonies, including testimony that was more than 11 years ago!

A spectator in the court told me, “You should have seen the spectacle created by GSK when it came time to do their cross.  They were so unorganized with their multiple binders that the jury started to laugh.”

Davis also went down the route of asking Glenmullen how much he was paid to give expert opinions in previous Paxil litigation. Leaves me wondering how much Todd Davis has been paid to defend one of the most controversial drugs in history. Further, I wonder whether he and his law team view their thousands of “settlements”as victory.

In what world is it viewed as a success to place gagging orders on families of Paxil victims so that the truth about the dangerous product is hidden?

Thus far, Davis has done a fine job of entertaining both spectators and jurors alike. Today’s Davis looks more like a sad clown than the smug clown who skipped into court three weeks ago. So, there you have it: King & Spalding attorneys seem to work well together if one considers their joint performance mere entertainment. Sad clown Davis and his jack-in-the-box sidekick, Andrew Bayman, will continue their lame cross-examination of Glenmullen today.

Bob Fiddaman

Federal lawsuit filed by widow blames Paxil for attorney’s suicide


By Amy Martyn

Amy Martyn is a writer and reporter who lives in Texas with her husband and dog. When she is not writing, reading or investigating, she is on her bicycle, running or on good days taking a road trip somewhere.  Read Full Bio→

Photo
Photo via Missd.co

Before committing suicide in 2010 at the age of 57, Stewart Dolin lived what his wife Wendy described as a “perfect life.” The Dolins had been married for 36 years and raised two children together, and Stewart at the time of his death was in charge of corporate and securities law at a prominent law firm in Chicago.

“This happy, funny, loving, wealthy, dedicated husband and father who loved life left no note and no logical reason why he would suddenly want to end it all,” Wendy Dolin writes on MISSD, or The Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin, the nonprofit she created in her late husband’s memory.

“Neither Paxil nor the generic version listed suicidal behavior as a potential side effect for men of Stewart’s age.”

Wendy Dolin is one of at least several people who have come forward publicly to blame the antidepressant Paxil for a loved one’s death. Her lawsuit against Paxil manufacturer GlaxoSmithKline, after having been stalled for years, is currently being heard before a jury in a Chicago federal court.

GSK criticized over handling of data on adolescents

The antidepressant Paxil had already brought GlaskoSmithKline an estimated $11.6 billion in sales when the company in 2012 was criminally prosecuted by the United States government, on charges that it was promoting Paxil for unapproved uses as well as hiding safety data about a different drug. That case ended with the United States government fining GSK a record $3 billion.

Since then, researchers have criticized GSK for its handling of evidence that paroxetine, the key ingredient in Paxil, is linked to suicide in young adults. The corporation had conducted a clinical trial in 2001 and reported positive findings — that paroxetine is “safe and effective for adolescents.” But a re-analysis of GSK’s own data, published in the British Journal of Medicine in 2015, found that 12 of the 93 children given paroxetine in the clinical trial reported suicidal thoughts.

“There is an increased risk of suicidality in pediatric and adolescent patients given antidepressants like paroxetine,” GSK acknowledged after the 2015 paper was published, pointing out that a black box label warning consumers as such had been placed on Paxil since 2004. But the researchers who analyzed GSK’s 2001 critical trial data argued that such a warning should have been on Paxil since the beginning.”What would have happened if this data were available 15 years ago when the study was originally published?,” one of the researchers said in an interview in Scientific American.

Wendy Dolin’s case charges that Paxil’s suicidal side effects aren’t limited to adolescents. Her attorneys are asking GSK similar questions about why they didn’t warn adult patients of a potential suicide risk.

Company blames FDA

Stewart Dolin’s family says that he had suffered some work-related anxiety shortly before his death. A family friend and doctor prescribed him the generic version of Paxil, which is produced by Mylan. The doctor, Martin Sachman, testified on Monday that he wouldn’t have prescribed paroxetine had he known about the suicide risk it posed in adults.

Dolin had been on paroxetine for six days, his family says, when he stepped in front of a commuter train after work.  His death was shortly after ruled a suicide. “Stu Dolin was a close personal friend, valued colleague and a great leader in our firm,” the head of his law firm told reporters shortly after the news broke.

GSK now acknowledges in court hearings that there is evidence of suicidal behavior in adults who take Paxil. “The results provided evidence of an increase in suicide attempts in adults with MDD [major depressive disorder] treated with paroxetine, compared to placebo, and that analysis based on the confidence interval was statistically significant,” a former bio-statistician for the company testified in one deposition, describing a 2006 study conducted by GSK.

But in testimony earlier this month, GSK told the federal jury that they were unable to warn consumers about this potential side effect becase the FDA had four times rejected its attempts to alter their own warning label. “The FDA controls the label, ladies and gentleman,” one of the GSK attorneys said at the trial, according to Law360. (A GSK spokeswoman has not yet returned an interview request from ConsumerAffairs.)

Wendy Dolin, who is accusing GSK of negligence by failing to warn doctors about the suicide risk, is asking for $12 million. Her suit is filed only against GSK, not Mylan, because the courts had determined in earlier proceedings that name-brand drugmakers, not their generic competitors, are ultimately responsible for the warning labels that go on all drugs.

Restlessness or something worse?

Little is known about Akathisia, the specific condition that Wendy Dolin says was caused by paroxetine and led to her husband’s suicide. Researchers have described Parkinson’s disease-like symptoms in some adults who take antipsychotic drugs, and others describe the condition as something similar to restless leg syndrome, or inability to sit still. Some critics, including personal injury attorneys and researchers, charge that the Akathisia disorder is linked not just to physical restlessness but intense emotional restlessness as well.

Among those warning of a dangerous link between Akathisia and antipsychotics is Dr. David Healy, a British psychiatrist who co-authored the 2015 re-analysis of GSK’s data showing an increased risk of suicide in adolescents. Healy, known as a gadfly in the pharmaceutical industry as well as in the field of psychiatry as a whole, is credited with convincing British and American regulators to place more warnings on antidepressants in 2004. Testifying on behalf of the the Dolin family earlier this month, he presented the jury with a study examining a link between Akathisia and Prozac, another popular antipsychotic medication. Both Paxil and Prozac are drugs classified as selective serotonin reuptake inhibitors, or SSRIs.

“Akathisia is a disorder, induced by SSRI medications, which can cause a person to experience such intense inner restlessness that the sufferer is driven to violence and/or suicide,” writes the memorial page that Wendy Dolin created in honor of Stewart. “It has been said, ‘Death can be a welcome result.’”

GSK’s attorneys, meanwhile, deny a link specifically between Akathisia and suicide, and they also deny that Paxil had anything to do with Dolin’s death. Instead they have reportedly blamed work-related stress, which as the American Lawyer points out is a common problem in the legal field. One study published by a commission for the American Bar Association last year claims that 28 percent of attorneys struggle with depression.

An $11 million verdict

But this is not the first trial examining the link between Paxil and adult suicide. In October, a jury awarded the family of 46-year-old Mumun Barbaros $11.9 million after he commited suicide in jail. Rather than suing the drug-maker, however,  his family blamed and sued the company that provided medical services at the jail for re-starting Barbaros on Paxil after he had been off of the medication for four days.

Dr. Peter Breggin, a psychiatrist and expert witness testifying on behalf of the family, said in a statement afterward that the verdict “illustrates the growing understanding within the judicial system and the public arena that psychiatric drugs can cause people to act in harmful ways that are contrary to their character and normal behavior.”

Bob Fiddaman Reports On The Glaxo Criminals…


http://fiddaman.blogspot.ie/2017/03/dolin-vs-gsk-day-8-get-to-point-todd.html?spref=tw

Tuesday, March 28, 2017

Dolin Vs GSK – Day 8 – Get to the Point, Todd!

The Todd Stance
 
Oh Todd, oh Todd, oh Todd,
you make us feel so weary.
Your questioning of Stewart’s doctor
really is quite dreary.
So, GSK’s warning letter
is the crux of your defence?
It’s not logical or rational;
it simply makes no sense.
You say you warned the doctors
of Paxil’s suicide risk.
Yet Andy Bayman denies this claim,
like a repeating compact disc.
Adults are perfectly safe, he states:
It’s just kids who should be warned.
But your former CEO confirms
it’s your duty to inform.
You can keep your fancy haircut, Todd,
and expensive Armani suit.
You can keep your sense of what’s right and wrong
in this wrongful death lawsuit.
You can keep your lack of due care
and misleading words of warning.
We know Paxil causes death, you see,
and leaves families deep in mourning.
Bob Fiddaman ~ 2017
Day 8 of the Dolin Vs GSK Paxil-induced suicide trial saw Stewart Dolin’s physician and long-time friend, Dr. Marty Sachman, take the stand.
Sachman was first questioned by David Rappaport, one of the attorneys representing Wendy Dolin (Stewart’s widow).
The jury heard more about Stewart Dolin, the man, and less about the fact that GlaxoSmithKline concealed Paxil’s propensity to induce suicidality. Sachman told the jury, “Stew was a very reserved, quiet, intelligent, loving man. I never heard him raise his voice over our 25-year relationship. We were like brothers. We spent weekends together, travel together. He was my closest friend. A loving person and a loving family man.” 
Sachman was also questioned about Stewart Dolin’s anxiety, which, according to the doctor, was a result of work-related issues. He told the jury that he never thought Stewart was depressed and that Stewart always responded to the treatment he gave him from 2005-2010. On each occasion, after Sachman prescribed Stewart drugs, he would warn him of the side effects and, once Stewart felt better, would wean him off the prescription.
Two days before Stewart’s Paxil-induced death, Sachman and Stewart attended a memorial service for the father of their mutual friend. Later that evening Sachman, Stewart and Wendy went to dinner together. Sachman was asked to describe what he remembered about Stewart that night. He answered, “His demeanor was, as usual, our conversation was as usual. He was calm.”
Sachman then recounted his “absolute shock” upon hearing the news of Stewart’s death. He told the jury, “I just think that we depend on honesty in reporting research and data. How can we treat people effectively and safely if we can’t depend on that?”
Rappaport then asked Sachman about the communication between pharmaceutical companies and doctors regarding drug labeling. Sachman’s answer, which King & Spalding objected to and was struck by the judge, highlighted Dr. Sachman’s feelings about being deceived:
 
“Well, you know, physicians, myself and millions of other physicians, every day try to protect people, try to help people and protect them. We rely on truth and honesty from pharmaceutical companies and to falsify information or hold back information is totally criminal. It affects the lives of our patients.”
It’s appropriate Sachman used the word ‘criminal’ given that GlaxoSmithKline have previously pled guilty to criminal charges. Therefore, GlaxoSmithKline are criminals.
Concluding his examining of the witness, David Rappaport asked Sachman about the tie and belt he was wearing. Sachman started to weep, sharing that they belonged to Stewart. Dr. Sachman wore them to “remember him today.”
Cross-examination by King & Spalding’s Todd Davis.
The cross-examination by Davis centered around GlaxoSmithKline’s “Dear Doctor Letters” sent out whenever GSK decides to share a problem with their products. Davis went over and over a series of these letters sent to Sachman. Sachman told Davis that he had, indeed, received these letters. Once again, King & Spalding tried to catch a witness by asking the same questions that were asked years ago during deposition. GSK’s attorneys futilely tried this tactic with Dr. David Healy and Dr. David Cross earlier in the trial.
Davis droned on about the “Dear Doctor Letters” and whether Sachman read them. Finally, an understandably frustrated Judge Hart interjected and admonished Davis, “You’re covering the same ground…over and over again now, Mr. Davis…Let’s not go over the same thing over and over again.”
Davis, however, continued to go over the “Dear Doctor Letters,” and the judge again interjected, “Mr. Davis, the document speaks for itself, and the doctor has accepted it. I don’t see any reason to read the document to him and ask him whether he agrees or disagrees.” 
 
King & Spalding’s “finest” then switched gears, inquiring about Sachman’s prescription of Levaquin (an antibiotic) to Stewart Dolin. Davis asked Sachman if he had read the Levaquin warnings regarding the drug’s propensity to cause adverse effects including suicidal acts or thoughts.
It’s good to see Levaquin manufacturers use the appropriate suicidal acts in their warning label. This term is surely more understandable than the intentionally ambiguous “emotional lability” term GSK prefers. I can’t help but wonder whether Davis would be equally concerned if his spouse consumed a product that states it can cause “emotional labilty” as he would if the warning listed “suicidal acts?”
Bizarrely, Davis next asked Sachman if he was aware Stewart’s widow and children had taken trips in and out of the US since Stewart’s death? Davis likely knows this is irrelevant, but shamelessly asked anyway in a lame attempt to imply Stewart’s widow and children couldn’t possibly be mourning Stewart’s Paxil-induced death if the family has traveled in the last six years. An appropriate question on my mind is “Does Davis take trips in and outside the US after settling cases for GSK in which innocent consumers have died?”
Davis finished his cross-examination, and I presume the jury and judge were glad to have a break from Davis’ tedious repetition. Davis is largely ineffective; GSK might want to reexamine their legal fund investment in Davis when GSK is, no doubt, embroiled in future wrongful death lawsuits.
David Rappaport – Re-direct
I won’t go into too much detail regarding the re-direct because the following question and answer seemed to undue Davis’ performance:
Q. Have you seen in any of the labels that you’ve ever seen from GSK about Paxil any reference to the fact that they had a suicide signal from attempts and suicides in the initial clinical trials that was of the magnitude of 7 to 8 times greater risk than similarly-depressed people on placebo?
A. I certainly have not.
Before leaving the stand, Dr. Marty Sachman told the jury, “I’d like to say that in the midst of all of this attempted confusion of the real issue here, if it was clear that this drug had a higher risk of causing suicide in the age group Stewart Dolin was in, I would have never prescribed it.”
Three doctors have now taken the stand:  All have stated if they had known about the increase in suicidality and behavior in adults taking Paxil they would have never prescribed it.
Your move, Todd!
The trial continues today with a series of video depositions that, sadly, I won’t have access to unless they are made public.
Bob Fiddaman.